- Home
- TLPH
TLPH
Talphera Inc.
as 07-26-2024 4:00pm EST
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | SAN MATEO |
| Market Cap: | 17.5M | IPO Year: | 2011 |
| Target Price: | $4.50 | AVG Volume (30 days): | 31.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.85 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.43 - $1.61 | Next Earning Date: | 08-08-2024 |
| Revenue: | $651,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Talphera Inc. (TLPH)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Angotti Vincent J. | TLPH | CHIEF EXECUTIVE OFFICER | Jun 12 '24 | Buy | $0.97 | 4,570 | $4,438.38 | 179,502 | SEC Form 4 |
| Angotti Vincent J. | TLPH | CHIEF EXECUTIVE OFFICER | Jun 12 '24 | Buy | $0.97 | 4,126 | $4,013.36 | 174,932 | SEC Form 4 |
| Angotti Vincent J. | TLPH | CHIEF EXECUTIVE OFFICER | Jun 12 '24 | Buy | $1.08 | 1,304 | $1,404.41 | 180,806 | SEC Form 4 |
Latest Talphera Inc. News
TLPH Breaking Stock News: Dive into TLPH Ticker-Specific Updates for Smart Investing
PR Newswire
2 months ago
Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
2 months ago
Talphera to Participate at A.G.P. Virtual Healthcare Conference
PR Newswire
2 months ago
Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update
PR Newswire
3 months ago
Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024
PR Newswire
5 months ago
Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update
PR Newswire
5 months ago
Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members
PR Newswire
5 months ago
Talphera to Host Fourth Quarter and Full-Year 2023 Financial Results Call and Webcast on March 6, 2024
Business Wire
6 months ago
Intellicheck Achieves ISO/IEC 27001:2013 and ISO/IEC 27001:2019 Recertification
Compare TLPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TLPH Talphera Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.